← Back to all trials
Recruiting
NCT07706777
Clinical Study of HRS-2129 for Acute Gouty Arthritis
Conditions: Acute Gouty Arthritis
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: PHASE2
Enrollment: 90
Sponsor: Shandong Suncadia Medicine Co., Ltd.
Location: The Third Affiliated Hospital of Sun Yat-sen University Guangzhou Guangdong
Summary
The study is being conducted to evaluate the safety, and efficacy of HRS-2129 for acute gouty arthritis. To explore the reasonable dosage of HRS-2129 for acute gouty arthritis.
Eligibility Criteria
Inclusion Criteria:
1. Able and willing to provide a written informed consent
2. Subjects requiring Acute gouty arthritis
3. Target joint VAS pain score ≥ 50 mm (screening)
Exclusion Criteria:
1. Subjects with a history of severe allergies
2. Subjects with nervous system disease
3. Subjects with a history of mental illness
4. Subjects with abnormal liver and renal function
5. Subjects with poorly controlled hypertensive
6. QTc：\>450ms（male），\>470ms（female）
7. History of cardiac dysrhythmias requiring anti-arrhythmia treatment(s)
8. The investigators determined that other conditions were inappropriate for participation in this clinical trial
Source: ClinicalTrials.gov (NCT07706777). StuddyBuddy aggregates publicly available trial information.
